Meeting
2021 ASCO Annual Meeting
Diagnostic performance of Gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging in early-relapsed prostate cancer: Phase 3, prospective, multicenter study (IAEA-PSMA study).
Authors
Juliano J Cerci
Quanta-Diagnóstico e Terapia, Curitiba, Brazil
Juliano J Cerci , Stefano Fanti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer–Local-Regional Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5078)
DOI
10.1200/JCO.2021.39.15_suppl.5078
Abstract #
5078
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2023 ASCO Annual Meeting
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
First Author: Clayton P Smith
Poster
2023 ASCO Genitourinary Cancers Symposium
Detection of true positive M1 lesions by 18F-rhPSMA-7.3 PET in newly diagnosed prostate cancer: Results from the phase 3 prospective LIGHTHOUSE study.
First Author: Bridget F. Koontz
Poster
2019 ASCO Annual Meeting
A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR).
First Author: Michael J. Morris